BioSpace News Archive

Biotech Bay

New Data Show Genentech’s Enspryng Significantly Reduces Severity and Risk of Relapse in Neuromyelitis Optica Spectrum Disorder

Enspryng was recently approved by the U.S. Food and Drug Administration (FDA) for adults with anti-aquaporin-4 (AQP4) antibody positive NMOSD

September 10, 2020
·
13 min read
Theratechnologies Announces Launch of Trogarzo® in Germany

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that Trogarzo® will be commercially available in Germany as of tomorrow through its subsidiary, Theratechnologies Europe Limited.

September 10, 2020
·
5 min read
New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Chugai Pharmaceutical Co., Ltd. announced the presentation of new Enspryng® data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder, a rare disease of the central nervous system.

September 10, 2020
·
7 min read
ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

ASLAN Pharmaceuticals, a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced its presentation at the H.C. Wainwright 22nd Annual Global Investment Conference.

September 10, 2020
·
3 min read
Medical Waste Containers Market: Non-infectious Waste Segment to be Highly Lucrative Segment

Transparency Market Research has published a new report titled, ‘Medical Waste Containers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

September 10, 2020
·
8 min read
Medical Devices Calibration Services Market: Patient monitoring system is the segment which is expected to propel the global market

Medical equipment calibration is the process which ensure the output of the medical devices is as per the industry standards.

September 10, 2020
·
5 min read
Deals

Casma Therapeutics Announces $50 Million Series B Financing

Proceeds will be used to advance Casma’s First-in-Class TRPML1 agonist in muscular dystrophy and enable preclinical proof-of-concept for the Company’s novel autophagy degrader platform

September 10, 2020
·
3 min read
Drug Development

New England Journal of Medicine publishes positive final results from phase 1/2a study of BIVV001 in people with severe haemophilia A

BIVV001 is the first investigational factor VIII therapy independent of von Willebrand factor and has the potential to transform replacement therapy for people with haemophilia A

September 10, 2020
·
7 min read
Drug Development

Electromedical Technologies and Nazarbayev University to Launch Phase I Research Program to Define Potent Electrical Frequencies Through Animal Models

Electromedical Technologies, Inc. is pleased to announce the launch of a Phase 1 research program in collaboration with Nazarbayev University to identify the most effective electrical frequencies for driving physiological responses in animal models.

September 10, 2020
·
6 min read
BioCapital

IZI Medical Receives CE Mark Approval for Kiva™ VCF Treatment System

IZI Medical Products, LLC (“IZI”), a leading manufacturer of interventional radiology devices, announces that it has received CE Mark approval in Europe for the KivaTM Vertebral Compression Fracture (VCF) Treatment System.

September 10, 2020
·
2 min read